Combined Synopsis/Solicitation & Notice of Intent to Sole Source: Acquisition of Element Biosciences AVITI Sequencing System

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

FDA OFFICE OF ACQ GRANT SVCS

Contract Value

Not provided

Codes & Classification
Solicitation Number

75F40126Q00233

NAICS

334516 - Analytical Laboratory Instrument Manufacturing

Classification Code

6640

Additional Details
Set Aside

None

Place of Performance

College Park, Maryland, UNITED STATES

SourceSAM
Documents1
The Food and Drug Administration (FDA), operating under the Department of Health and Human Services, has issued a combined synopsis/solicitation (Solicitation No. 75F40126Q00233) for the acquisition of the Element Biosciences AVITI Sequencing System. This procurement is being conducted by the FDA Office of Acquisition and Grant Services, with the place of performance specified as College Park, Maryland. Purpose and Scope: The primary objective of this procurement is to acquire a state-of-the-art AVITI Sequencing System from Element Biosciences. This advanced laboratory instrument is intended to support the FDA’s ongoing analytical and research activities, enhancing the agency’s capabilities in high-throughput sequencing and laboratory analysis. The acquisition aligns with the FDA’s mission to ensure public health and safety through rigorous scientific evaluation and regulatory oversight. Key Requirements and Deliverables: The solicitation specifies the need for a commercial item—specifically, the AVITI Sequencing System—manufactured by Element Biosciences. The system must meet the FDA’s stringent requirements for analytical laboratory instrumentation, as classified under NAICS Code 334516 (Analytical Laboratory Instrument Manufacturing) and Product Service Code 6640 (Laboratory Equipment and Supplies). The expected deliverable is the complete sequencing system, delivered and installed at the designated FDA facility in College Park, Maryland. Contracting Details: - Contract Type: Firm Fixed Price (FFP), ensuring price certainty for the government and the contractor. - Acquisition Method: This is a sole source procurement under FAR 6.103-1, as only Element Biosciences is deemed capable of providing the required system to meet the agency’s needs. No other supplies or services will satisfy the requirements. - Set-Aside Status: The acquisition is not set aside for small business concerns. - Solicitation Process: This notice serves as both the synopsis and the solicitation. No separate written solicitation will be issued. Interested parties may submit quotations, but the government intends to negotiate exclusively with Element Biosciences. Relevant Entity and Contact Information: - Contracting Entity: FDA Office of Acquisition and Grant Services - Department: Health and Human Services, Food and Drug Administration - Place of Performance: College Park, Maryland, USA - Primary Contact: Natalie Brown ([email protected]) - Secondary Contact: Maeve Xavier ([email protected]) Additional Considerations: The solicitation incorporates applicable provisions and clauses by reference, accessible via www.acquisition.gov. While this is a sole source action, the FDA will consider any responsible quotes received. The procurement is governed by the 2022 version of the NAICS code and adheres to federal acquisition regulations. Contractors evaluating this opportunity should note that the requirement is highly specific to the AVITI Sequencing System from Element Biosciences, and the procurement is structured to ensure compatibility with existing FDA research protocols and infrastructure. The contract will remain firm fixed price throughout its lifecycle, with performance and delivery expected at the College Park, Maryland location. For further details, interested parties are encouraged to review the attached Request for Quotation (RFQ) and direct any inquiries to the listed contacts. The notice remains active, with responses due by August 18, 2026. For more information, visit the official notice at: https://sam.gov/opp/791b999520d24fa391741e54744cf5e9/view